Natixis’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,500
Closed -$57.8K 1052
2023
Q4
$57.8K Buy
+2,500
New +$57.8K ﹤0.01% 789